FAST NEWS: CanSino’s Inhaled Covid Booster Gets China Green Light
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Sunday that China’s National Medical Products Administration (NMPA) have given emergency use authorization for its inhaled recombinant Covid-19 vaccine for use as…
RELATED ARTICLES
-
Health Guard plans dual listing to fund HPV vaccine fight
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: Fiscal Revenue, Land Sales Fall in April
-
FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
6185.HK 688185.SHG
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
- CHINA BULLETIN: China Economy Off to Strong Start in 2024
